Darwin Global Management’s Alpine Immune Sciences Inc ALPN Stock Holding History

Darwin Global Management’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,982,016	Closed	-$78.6M	–	17
2024 Q1	$78.6M	Buy	+1,982,016	New	+$58.5M	10.46%	5

Darwin Global Management's ALPN Position: Q2 2024 in Review

Darwin Global Management sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 1,982,016 shares — an estimated $78.6M sold.

Darwin Global Management first reported a position in ALPN in Q1 2024 and held it in 1 quarter. The position peaked at $78.6M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

Darwin Global Management reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
Darwin Global Management sold 1,982,016 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $78.6M.
Darwin Global Management first reported a position in Alpine Immune Sciences Inc in Q1 2024 and held it in 1 quarter.
Darwin Global Management's Alpine Immune Sciences Inc position peaked at $78.6M in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Darwin Global Management's 13F filing for Q2 2024, filed 14 Aug 2024.